Most importantly, gene expression profiling in our transgenic model showed that belinostat induced a common set of core HDAC genes similar to those previously reported in the T24 human bladder cancer cell line treated with different HDACIs [38]. The gene discussed is HDAC9; the disease is urinary bladder carcinoma.